What is Neolight?
NeoLight LLC is at the forefront of neonatal care innovation, developing advanced products designed to enhance the health and well-being of newborns. Their product portfolio includes the Skylife Neonatal Phototherapy System for jaundice treatment, sophisticated brain monitoring solutions, and essential ocular screening tools. The company also provides non-nutritive sucking aids and educational resources for healthcare professionals, underscoring a commitment to improving neonatal outcomes. NeoLight's mission is to empower hospitals and healthcare providers with cutting-edge technology and empathetic solutions, aiming to set new standards in newborn care.
How much funding has Neolight raised?
Neolight has raised a total of $7.8M across 3 funding rounds:
Angel/Seed
$600K
Debt
$150K
Unspecified
$7M
Angel/Seed (2016): $600K, investors not publicly disclosed
Debt (2020): $150K led by PPP
Unspecified (2020): $7M supported by Ashley Roethlisberger, Ben Roethlisberger, Honor Health Systems, and Dignity Health
Key Investors in Neolight
Dignity Health
Dignity Health is a prominent healthcare system, likely investing in companies that align with improving patient care and health outcomes, particularly within hospital settings.
Honor Health Systems
Honor Health Systems, as a healthcare provider, would be interested in innovative medical technologies that enhance the quality and efficiency of care delivered to patients.
Ashley Roethlisberger
An individual investor, potentially with a background or interest in healthcare innovation or early-stage ventures.
What's next for Neolight?
With a substantial enterprise-level funding context, Neolight is strategically positioned for significant scaling and further product development. The recent major strategic investment suggests a strong validation of their innovative approach to neonatal care and market potential. This capital infusion is likely to accelerate the expansion of their product lines, enhance manufacturing capabilities, and broaden their market reach within the healthcare sector. Future growth may involve deeper integration of their brain monitoring and phototherapy systems, alongside continued development of their ocular screening and supportive care tools, solidifying their role as a key player in neonatal health technology.
See full Neolight company page
